Healthcare Sales & Marketing Network News: RAPINYL

Searching News Database: RAPINYL

HSMN NewsFeed - 2 Mar 2009
Orexo's AbstralTM Receives Two Further Large EU Market Approvals in France and Spain
Biopharmaceuticals Regulatory

HSMN NewsFeed - 11 Dec 2008
Abstral receives marketing approval in Germany
Biopharmaceuticals Regulatory

HSMN NewsFeed - 31 Jul 2008
Orexo and ProStrakan Extend Licensing Agreement for Rapinyl/Abstral and change Partner in North America
Biopharmaceuticals Licensing

HSMN NewsFeed - 9 Jun 2008
Orexo Strengthens the Executive Management Group
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Apr 2008
Endo Pharmaceuticals Provides Updates on FROVA(R) and CHRONOGESIC(R) Clinical Development Programs
Biopharmaceuticals

HSMN NewsFeed - 7 Mar 2008
Orexo: Rapinyl(TM) has Received Swedish Marketing Authorization
Biopharmaceuticals Regulatory Drug Delivery

HSMN NewsFeed - 17 Dec 2007
Endo Announces Positive Results From Interim Analysis of RAPINYL(TM) Phase III Clinical Trial
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 25 Oct 2007
Orexo Signs Distribution Agreement with Hospira in Asia for Pain Product Rapinyl(TM)
Biopharmaceuticals Distribution

HSMN NewsFeed - 28 Sep 2007
Orexo: Orexo's Rapinyl(TM) Nearing Regulatory Decision in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 1 Aug 2007
Orexo Establishes Sales Force in Nordic Markets, by Entering into a Joint Venture with ProStrakan
Biopharmaceuticals

HSMN NewsFeed - 12 Oct 2006
Endo Pharmaceuticals Acquires RxKinetix, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions

Return to NewsFeed

Additional items found! 2

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 2 additional stories matching:
RAPINYL
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.